Screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared with no screening, according to a recent study.
Once-only flexible sigmoidoscopy screening, with or without fecal occult blood testing (FOBT), is associated with reduced colorectal cancer incidence and mortality, according to a study.
A new study adds support to current medical recommendations stating that screening colonoscopy substantially reduced the likelihood of advanced CRC in either the right or left side of the colon being diagnosed in an average-risk adult.
The use of colonoscopy to screen for colorectal cancer may explain the significant decrease in the incidence of that cancer over the past decade. While colonoscopy is now the most common colorectal cancer screening method, evidence has conflicted about how its effectiveness compares with sigmoidoscopy.
Screening linked to reduced incidence in proximal and distal CRC, reduced mortality for distal CRC
The disparities seen in colorectal cancer screening rates appear to be linked not only to racial/ethnic factors but also geography, according to a study of screening status among Medicare enrollees.
Reducing the risk of developing bowel cancer may be possible through the use of a 5-minute screening test, according to a study published in the Lancet.
CT colonography (CTC) has comparable sensitivity to colonoscopy for polyps >5mm, say researchers in Germany.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|